No Data
Express News | Perceptive Advisors LLC - Had Previously Reported 5.8% Stake in VBI Vaccines as of Nov 17, 2023
Express News | Perceptive Advisors LLC Reports 4.4% Stake in VBI Vaccines as of April 16 - SEC Filing
Express News | VBI Vaccines Inc : Raymond James Cuts Target Price to $5 From $6
VBI Vaccines FY Non-GAAP EPS of $3.96
VBI Vaccines Soars With Hepatitis B Vaccine Success
VBI Vaccines 2023 Rev $8.7M >VBIV
VBI Vaccines 2023 Rev $8.7M >VBIV